Publications by authors named "Marta Mir"

Claim this Profile
T
Topical Insulin for Ocular Surface Disease.
Pau Cid-Bertomeu, Magí Vilaltella, Mireia Martínez, Marta Mir, Valentín Huerva

J Ocul Pharmacol Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases.
Montse Erra, Joan Taltavull, Francisco Javier Bernal, Juan Francisco Caturla, Marta Carrascal, Marta Mir, Montserrat Miralpeix

J Med Chem· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists I.
Juan Antonio Alonso, Miriam Andrés, Mónica Bravo, Maria Antonia Buil, Marta Calbet, Marta Mir, Miriam Zanuy

Bioorg Med Chem Lett· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: lead optimization.
Juan Antonio Alonso, Miriam Andrés, Mónica Bravo, Marta Calbet, Paul R Eastwood, Marta Mir, Miriam Zanuy

Bioorg Med Chem Lett· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: the role of a hydrogen-bond acceptor in long receptor residence times.
Juan Antonio Alonso, Miriam Andrés, Mónica Bravo, Maria Antonia Buil, Marta Calbet, Marta Mir

Bioorg Med Chem Lett· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonists.
Nuria Aguilar, Marta Mir, Pedro M Grima, Manel López, Victor Segarra

Bioorg Med Chem Lett· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly potent aminopyridines as Syk kinase inhibitors.
Marcos Castillo, Pilar Forns, Montse Erra, Marta Mir, Manel López, Montserrat Miralpeix

Bioorg Med Chem Lett· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indolin-2-one p38α inhibitors III: bioisosteric amide replacement.
Paul Eastwood, Jacob González, Elena Gómez, Francisco Caturla, Nuria Aguilar, Marta Mir

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis